Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
Archives: Search / 2023 / 2022 / 2021 / 2020 / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013
Matt Alberico joins Dario to help manage expanding growth opportunities after successfully driving customer growth at Amazon Care, Cigna and Aetna NEW YORK, Jan. 24, 2023 /PRNewswire/ --...
MoreDarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital therapeutics (DTx) market, announced today the publication of new research in the peer-reviewed journal...
MoreNortheast supermarket chain will deploy Dario's cardiometabolic suite in 2023 NEW YORK, Jan. 3, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the...
MoreDario Move to be deployed in Greece and Cyprus to help improve the musculoskeletal health of the general populations New York, Dec. 22, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the...
MoreDarioHealth Corp. (NASDAQ: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced the publication of a new study in the peer-reviewed journal Frontiers in...
MoreThe new accounts originated through an existing relationship with a benefits brokerage and provide further validation of Dario's partnership Strategy. NEW YORK, Dec. 1, 2022 /PRNewswire/ --...
MoreDarioHealth Corp. (Nasdaq: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced today that management will participate at the following conferences: 13th...
MoreThird quarter 2022 revenues of $6.6 million increased 17.3% from $5.6 million in the third quarter of 2021 driven by growth in Business-to-Business (B2B) revenues. Nine-month year to date revenue...
MoreDarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the third quarter ended September 30, 2022,...
MoreNew 'jumbo' employer account represents increasing penetration of the Dario platform NEW YORK, Oct. 20, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader...
MoreDario to support City employees with integrated solutions addressing diabetes, hypertension, weight management, musculoskeletal and behavioral health in company's first government contract win NEW...
MoreNew research sheds light on the importance of training to drive healthier posture NEW YORK, Sept. 22, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital...
MoreNew accounts demonstrate continued demand for integrated and holistic digital chronic condition management solutions NEW YORK, Sept. 20, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the...
More